A first-of-its-kind, single-dose non-integrating gene therapy that increases your body’s production of Follistatin-344, a protein that helps reduce aging signals, build lean muscle, decrease inflammation, and promote regenerative repair—all without altering your DNA or impacting fertility.

Follistatin works by neutralizing myostatin and activin—two proteins that restrict muscle growth and drive inflammation. By inhibiting these factors, Follistatin creates ideal conditions for the body to regenerate, build lean muscle, and heal more effectively.

No. Stem cell therapy introduces new cells into the body. Follistatin gene therapy, on the other hand, provides genetic instructions that empower your existing cells to repair and regenerate—treating the root cause rather than just the symptoms.

Results vary by individual, but clinical findings at 3 months post-treatment have shown:

↑ 2 lbs lean muscle mass
↓ 0.8% body fat
↓ Biological age by up to 12 years in some patients

 Many also report better energy, performance, and an overall sense of vitality.

Results typically last around 12 months, though biological shifts—especially at the genetic and epigenetic level—may persist longer depending on lifestyle and overall health.

Yes. Follistatin-344 has been evaluated in both primate and human trials with an excellent safety profile, and no negative effects on fertility or immune function. This variant avoids the hormonal disruption sometimes seen with other forms like Follistatin-288.

About one-third of patients may experience a minor increase in LDL cholesterol (approximately 8 ng/dL). This is typically considered clinically insignificant, and is reviewed on a case-by-case basis during your medical consultation.

While innovative, Follistatin gene therapy is built on decades of scientific research. The role of Follistatin in muscle growth and inflammation was first identified in 2001, with subsequent animal and human studies reinforcing its potential. Our current protocol is the result of rigorous development and physician-led application.

Emerging research is promising. A 2021 study (Jajyan) showed a 32.5% increase in lifespan in mice treated with Follistatin. While human longevity data takes time, these results offer compelling early evidence.

Healthy adults looking to improve muscle tone, reduce fat, enhance energy, or proactively slow the aging process. It’s also well-suited for high-performance individuals, biohackers, and those with age-related muscle loss. A medical consultation is required to determine eligibility.

Follistatin gene therapy doesn’t mask symptoms—it reprograms your biology at the cellular level. Unlike creams, supplements, or hormone therapies, this treatment restores the body’s natural ability to regenerate, making it a functional, not just cosmetic, solution to aging.